• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Drugs of today: Medicamentos de actualidad >Advances in management of malignant diseases with the combination of radiation therapy and chemotherapy. Highlights from the 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology.
【24h】

Advances in management of malignant diseases with the combination of radiation therapy and chemotherapy. Highlights from the 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology.

机译：放射疗法和化学疗法相结合在恶性疾病管理上的进展。美国放射治疗与肿瘤学会第45届年会摘要。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

From October 19 through October 24, 2003, the American Society for Therapeutic Radiology and Oncology held its 45th Annual Meeting in Salt Lake City, Utah. The meeting was devoted to the presentation of advances in the management of malignant diseases with radiation modalities. The meeting brought together investigators, clinicians, policy makers and professionals interested in the science and impact of radiation on cancerous disease. This report examines the advances in combined modality approaches (i.e., the use of radiation therapy and chemotherapy) for the treatment of malignant disease. The American Society for Therapeutic Radiology and Oncology sponsors an annual meeting devoted to the presentation of radiation-related advances in malignant disorders. The educational elements of this program are targeted at oncologists of all disciplines (i.e., surgical oncologists, medical oncologists, radiation oncologists), physicists, biologists, nurses, and therapists as well as all health care workers who are involved in the treatment of patients with malignant diseases. The program includes presentations on standard, investigational and experimental therapeutics as well as intensity-modulated radiation therapy, treatment planning, alternative fractionation, and molecular and radiation biology. Specific clinical areas include breast, central nervous system, gastrointestinal, genitourinary, gynecological, head and neck, and lung cancers. In addition, the program addresses quality of life, supportive care and socioeconomic issues. These topics are addressed by a combination of educational sessions, panel discussions, proffered papers and posters. Since a diminishing number of tumors can be managed solely by radiation therapy, among the most noteworthy developments this year were the combined modality approaches (i.e. radiation therapy combined with chemotherapy) in the treatment of malignant disease. In particular, a cluster of seminal papers was presented pertaining to colorectal and pulmonary (both small cell and non-small cell lung cancer) malignancies. This report focuses on the advances reported for those tumor types, which are among the most prevalent in the Western world.
机译：从2003年10月19日至10月24日，美国放射治疗与肿瘤学会在犹他州盐湖城举行了第45届年会。该会议专门介绍了利用放射方式治疗恶性疾病的进展。会议聚集了对放射线的科学及其影响感兴趣的研究人员，临床医生，政策制定者和专业人员。本报告探讨了联合方式治疗恶性疾病的进展（即使用放射疗法和化学疗法）。美国放射治疗与肿瘤学会协会主办了一次年度会议，专门介绍与放射有关的恶性疾病进展。该计划的教育内容面向所有学科的肿瘤学家（即外科肿瘤学家，医学肿瘤学家，放射肿瘤学家），物理学家，生物学家，护士和治疗师，以及参与治疗患有高脂血症的患者的所有卫生保健工作者。恶性疾病。该计划包括有关标准，研究和实验疗法以及强度调节放射疗法，治疗计划，替代分级分离以及分子和放射生物学的演讲。具体的临床领域包括乳腺癌，中枢神经系统，胃肠道，泌尿生殖系统，妇科，头颈癌和肺癌。此外，该计划还涉及生活质量，支持性护理和社会经济问题。这些主题可以通过教育会议，小组讨论，发表的论文和海报来解决。由于仅通过放射治疗就可以减少肿瘤的数量，因此，今年最值得注意的发展是用于治疗恶性疾病的联合治疗方法（即放射治疗与化学疗法相结合）。特别是，提出了一系列关于结直肠癌和肺癌（小细胞肺癌和非小细胞肺癌）的开创性论文。本报告重点介绍了这些肿瘤类型的报道进展，这些肿瘤类型在西方世界最为普遍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号